PPIG and neoplasm: According to the hypothesis of the present study, altered copy numbers of paclitaxel-metabolizing CYP enzymes as an intrinsic genetic profile of tumour subclones may potentiate them for an increase in CYP expression and metabolic activity that may contribute to the emergence of clones resistant to paclitaxel therapy.